Foghorn Therapeutics Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

FHTX

organization

SIC: 2834

SEC Insider

$76.8M

177 transactions

Summary

Foghorn Therapeutics Inc. (FHTX) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $24.9MSales: $3.4M36 insiders

Date	Insider	Type	Value
2026-02-05	GOTTSCHALK ADRIAN(Chief Executive Officer)	A	$5.6M
2026-02-23	Maynard Ryan D(Chief Financial Officer)	A	$2.3M
2026-01-30	Cardama Alfonso Quintas(Chief Medical Officer)	A	$1.7M
2026-01-30	Bellon Steven F.(Chief Scientific Officer)	A	$1.7M
2026-01-30	LaCascia Michael(Chief Legal Officer)	A	$1.7M
2026-01-30	Costa Carlos(Chief People Officer)	A	$1.3M
2026-01-30	Rivkin Anna(Chief Business Officer)	A	$942K
2026-06-24	PARSHALL B LYNNE	A	$114K
2026-06-24	GILL SIMBA	A	$114K
2026-06-24	SMITH IAN F	A	$114K
2026-06-24	Lynch Thomas J. Jr.	A	$114K
2026-06-24	Cole Douglas G.	A	$114K
2026-06-24	Biller Scott	A	$114K
2026-06-24	Mendelsohn Michael	A	$114K
2026-06-24	Duty Stuart	A	$114K
2026-06-24	Gallagher Neil	A	$114K
2026-04-10	GOTTSCHALK ADRIAN(Chief Executive Officer)	G	$0
2026-04-10	GOTTSCHALK ADRIAN(Chief Executive Officer)	G	$0
2026-04-09	GOTTSCHALK ADRIAN(Chief Executive Officer)	G	$0
2026-04-09	GOTTSCHALK ADRIAN(Chief Executive Officer)	G	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Foghorn Therapeutics Inc. — Contributions, Lobbying & Contracts | Poliscope